An oxalate-fermenting brown-rot fungus, Fomitopsis palustris, secretes large amounts 20 of oxalic acid during wood decay. Secretion of oxalic acid is indispensable for the 21 degradation of wood cell walls, but almost nothing is known about the transport mechanism 22 by which oxalic acid is secreted from F. palustris hyphal cells. We characterized the 23 mechanism for oxalate transport using membrane vesicles of F. palustris. Oxalate transport 24 in F. palustris was ATP dependent and was strongly inhibited by several inhibitors such as 25 valinomycin and NH 4 + , suggesting the presence of a secondary oxalate transporter in this 26 fungus. We then isolated a cDNA, Fomitopsis palustris Oxalic Acid Resistance (FpOAR), 27 from F. palustris by functional screening of yeast transformants with cDNAs grown on 28 oxalic acid-containing plates. FpOAR is predicted to be a membrane protein that possesses 29 six transmembrane domains, but shows no similarity with known oxalate transporters. The 30 yeast transformant possessing FpOAR (FpOAR-transformant) acquired resistance to oxalic 31 acid and contained less oxalate than the control transformant. Biochemical analyses using 32 membrane vesicles of the FpOAR-transformant showed that the oxalate transport property 33 of FpOAR was consistent with that observed in membrane vesicles of F. palustris. The 34 quantity of FpOAR transcripts was correlated with increasing oxalic acid accumulation in 35 the culture medium and was induced when exogenous oxalate was added to the medium.
5'-ACTAGTATGACCGACCTGCATCGAAG-3'
(sense) and 136 5'-GGATCCTCAGAGAAGATCTTCTTGCCG-3' (antisense), which were gene-specific 137 primers containing Spe I and the BamHI restriction site, respectively. The coding region 138 thus obtained was named FpOAR (Fomitopsis palustris Oxalic Acid Resistance).
139
Characterization of oxalic acid-resistance activity of FpOAR. The plasmid 140 containing FpOAR was reintroduced into the S. cerevisiae AD12345678 strain to 141 characterize its oxalic acid resistance according to our method reported previously (49) . 142 Oxalic acid resistance was determined by growth of the yeast transformant. Similarly, the 143 transformants were cultivated separately on SD (-Ura) plates containing different HCl 144 concentrations (pH 1.5, 1.6, and 2.2).
145
Quantification of oxalic acid. Oxalic acid in the F. palustris culture medium was 146 quantified with a commercial kit after the pH of the medium was adjusted for the assay 147 (Roche, Germany) (48), while GC-MS analysis (14) was conducted for that in yeast cells.
148
Yeast (OD 600 0.1) was cultured at 30°C in 50 ml SD (-Ura) liquid medium containing 2 149 8 mM oxalic acid until OD 600 1.0-2.0. The cells were harvested by centrifugation at 1000×g 150 for 10 min and washed twice with cold distilled water. The dry weight of cells was 151 determined after freeze-drying for 5 h. To the dried cells, 250 µl 1N HCl and 600 µl 152 ethylacetate were added and cells were homogenized with glass beads (Toshinriko, No. 04) 153 for 4 min. The oxalic acid extracted with ethylacetate was quantified as previously 154 described (14). Biosystems) and amplicons were detected with SYBR Green (Applied Biosystems).
163
Quantifications of the amplicons were based on standard curves prepared for each target 164 cDNA. The gene-specific primers 5'-CCTCGAACAAGCGAATTCTCTTT-3' and Healthcare) by filtration with an aspirator. The vesicles on the membrane were washed 217 three times with 1 ml transport buffer by filtration with an aspirator, dried on filter paper 218 and subjected to liquid scintillation counting. Counts were corrected for background and 219 quenching. Quantification and calculations were performed using a Liquid Scintillation 220 Analyzer Tri-Carb 2800TR (Perkin Elmer, USA).
221
Effects of inhibitors on oxalate transport. Using F. palustris vesicles, the following 222 inhibitors were added separately to assay solutions: 1 mM vanadate, 2 µM valinomycin, 1 223 mM NH 4 Cl, 150 µM glibenclamide, or 5 µM cyclosporin A. Oxalate transport was 224 recorded as described above.
225
To assess the inhibition using yeast vesicles from the FpOAR-transformant, we used 5 226 µM verapamil, and 5 µM gramicidin D in addition to the reagents used for the F. palustris 227 vesicle assay. Oxalate transport was recorded as described above.
228
Statistical analysis. Analyses were carried out using ANOVA followed by the Dunnett 229 test with a level of significance of p = 0.05. that oxalate is more toxic than malonate (Fig. 3C) . To eliminate the possibility that the FpOAR-transformant strongly decreased to 25% compared with that of the control (Fig. 4) .
279
Oxalate transport in vesicles of the the assay was conducted at 4 C or with vesicles denatured at 95 C, oxalate transport did 283 not differ from that of the empty vector control (Fig. 5) .
284
Vanadate and gramicidin D, which are inhibitors of P-type ATPases and a 285 monovalent-selective ionophore that dissipates both the pH gradient and membrane 286 potential, inhibited oxalate transport by 28.5% and 55.8%, respectively (Fig. 6) .
287
Valinomycin and NH 4 Cl, which abolish ΔΨ and ΔpH across the membrane, respectively, (Figs. 7A, B and C) . High levels were maintained even in the stationary 297 phase during days 9-13, while oxalic acid accumulation increased (day 13, 34 mM). The 298 amount of FpOAR transcripts increased three-fold compared with that of the control when 299 50 mM oxalic acid was added to the medium (Fig. 8) . on yeast vesicles (Fig. 6 ) were similar to those on vesicles from F. palustris (Fig. 1) .
313
Furthermore, expression of FpOAR and oxalic acid accumulation in the medium were 314 positively correlated (Fig. 7A, B and C) . Expression of FpOAR was induced by addition of 315 oxalic acid to the culture (Fig. 8) . Collectively, these results strongly suggest the 316 involvement of FpOAR as a secondary oxalate transporter to confer oxalic acid resistance 317 in F. palustris.
318
FpOAR is a plasma membrane-localized novel secondary oxalate transporter. 319 FpOAR is proposed to be a novel oxalate secondary transporter based on three lines of FpOAR is suggested to be a plasma membrane oxalate efflux transporter based on the 326 lower oxalate content in the FpOAR-transformant compared with the control (Fig. 4) Figure S1 
